This Event has now run. Thank you to our Speakers, Sponsors, and Delegates who joined us in London for the Summit!

If you are interested in the 2025 event, please get in touch at

The CAR-TCR Series: Your European Hub of Next Generation Cell Therapy Innovation

Cell therapy continues to transform the oncology field with advances across in vivo engineering and novel armouring enhancements. Despite investment challenges, innovation is not slowing for those working in CAR-TCR drug development.  

Providing exclusive access to the most cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe was the must-attend forum to stay at the forefront of cell therapy innovations.  

Cell therapy industry experts united in London in February 2024 at the only cell therapy conference looking in-depth at boosting clinical durability, advancing predictive biomarkers, and implementing safety switches through to automating production and accelerating analytical processes to reduce operational costs and turnaround times; and new cell therapy technology.  

In attendance alongside key investors were leading next-gen stakeholders like ImmPACT Bio, ImmaticsCaribou Bio, Umoja BiopharmaMnemo Therapeutics, and ArsenalBio.

Who Attended:

abbvie adaptimmun advesya anocca astrazeneca arsenal bio cabaletta bio
capstan therapeutics caribou biosciences carisma therapeutics celyad oncology cellectis cemm etcembly
gentibio glycostem immatics iaso biotehrapeutics bambino gesu impact bio johnson & johnson
Kite Pharma Legend Biotech Kyverna Medigene Leucid Bio Mnemo Therapeutics Novartis
Quell Therapeutics Sacred Heart University T-Curx Tigen Pharma T-Knife Therapeutics Umoja Biopharma Zelluna Immunotherapy
About Event
Home Page (Full & Busy Conference)
Speaker Page

“The advancement of cell therapies to next generation and beyond will take substantial collaboration amongst the community. This cell therapy conference presents a great opportunity for companies and executives to connect on issues and opportunities alike and find common ground to move forward.”

Brian Kobel, Chief Executive Officer, TC Biopharm
2024 Speaker

What Was New for 2024?

Investor & Biopharma Partnerships Evening:

Gain insight into the decision making made by investors and network to create valuable connections to support future funding strategy

C-Level Think Tank:

An exclusive collaboration opportunity to discuss the industry’s most critical challenges

New Clinical Data From:

IRCCS Bambino Gesu Children’s Hospital, Immatics, Caribou Biosciences, Carisma Therapeutics, and Kyverna Therapeutics

Experts on the 2024 Speaker Faculty:

2024 Expert Speakers Included:

Gwen Binder

President, Science & Technology

Cabaletta Bio

Helen Tayton-Martin

Chief Business Officer


Adrian Bot


Capstan Therapeutics

Barbara Lösch

Head of Technology & Innovation


Dorothea Ledergerber

Chief Technical Officer

Tigen Pharma

Jacob Hurst

Chief Technology Officer & Co-Founder


John Maher

Chief Scientific Officer

Leucid Bio

Samik Basu

Chief Scientific Officer

Cabaletta Bio

“The 7th CAR-TCR Summit Europe provides a unique opportunity for leaders in the cell/gene therapy field to hear of all the advances made and importantly network with other leaders.”

David Fontata, Chief Business Officer & Chief Operating Officer, Umoja Biopharma
2024 Speaker

Who Attended in 2024:

2024 Partners:

Expertise Partners:
Emerson - Expertise Partner
Terumo - Expertise Partner
Programme Partners:
Akron Bio - Programme Partner
Beacon - Programme
Catalent - Programme Partner
FUJIFILM - Programme Partner
ProBio - Programme Partner
MaxCyte - Programme Partner
Miltenyi Biotec - Programme Partner
ScaleReady - Programme Partner
SK Pharmteco

"CAR-TCR London is a must in the calendar, a uniquely focused cell therapy conference to stay updated on the key trends and innovations in the development and manufacturing of these innovative and exciting therapies."

Lindsey Clarke, Co-Founder, The CGT Circle